Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years (vol 25, pg 1197, 2010)

被引：1

作者：

Kim, Young-Jae ^{[1
]}

Kim, Kyung-Tai ^{[1
]}

Kim, Jae-Hoon ^{[2
]}

Cha, Soon-Do ^{[3
]}

Kim, Jae Weon ^{[4
]}

Bae, Duk-Soo ^{[5
]}

Nam, Joo-Hyun ^{[6
]}

Ahn, Woong-Shick ^{[7
]}

Choi, Ho-Sun ^{[8
]}

Ng, Timothy ^{[9
]}

Bi, Dan ^{[9
]}

Ok, Jin-Ju ^{[9
]}

Descamps, Dominique ^{[9
]}

Bock, Hans L. ^{[9
]}

机构：

[1] Hanyang Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea

[2] Yonsei Univ, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul 120749, South Korea

[3] Keimyung Univ, Dept Obstet & Gynecol, Dongsan Med Ctr, Taegu, South Korea

[4] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul 110744, South Korea

[5] Sungkyunkwan Univ, Dept Obstet & Gynecol, Samsung Med Ctr, Seoul, South Korea

[6] Univ Ulsan, Dept Obstet & Gynecol, Asan Med Ctr, Seoul, South Korea

[7] Catholic Univ Korea, Dept Obstet & Gynecol, Seoul St Marys Hosp, Seoul, South Korea

[8] Chonnam Natl Univ Hosp, Dept Obstet & Gynecol, Kwangju, South Korea

[9] GlaxoSmithKline Biol, Wavre, Belgium

来源：

JOURNAL OF KOREAN MEDICAL SCIENCE | 2010年 / 25卷 / 12期

关键词：

D O I：

10.3346/jkms.2010.25.12.1831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1831 / 1831

页数：1

共 50 条

[31] AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®) A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types
McKeage, Kate
Romanowski, Barbara
DRUGS, 2011, 71 (04) : 465 - 488
[32] AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): A review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types
McKeage K.
Romanowski B.
Drugs, 2011, 71 (4) : 465 - 488
[33] Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls
Schmeink, Channa E.
Bekkers, Ruud L. M.
Josefsson, Ann
Richardus, Jan H.
Blom, Katarina Berndtsson
David, Marie-Pierre
Dobbelaere, Kurt
Descamps, Dominique
VACCINE, 2011, 29 (49) : 9276 - 9283
[34] Randomized Trial: Immunogenicity and Safety of Coadministered Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine and Combined Hepatitis A and B Vaccine in Girls
Pedersen, Court
Breindahl, Morten
Aggarwal, Naresh
Berglund, Johan
Oroszlan, Gyoergy
Silfverdal, Sven Arne
Szuts, Peter
O'Mahony, Michael
David, Marie-Pierre
Dobbelaere, Kurt
Dubin, Gary
Descamps, Dominique
JOURNAL OF ADOLESCENT HEALTH, 2012, 50 (01) : 38 - 46
[35] Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9-14 Years Versus a 3-Dose Regimen in Women Aged 15-25 Years
Puthanakit, Thanyawee
Huang, Li-Min
Chiu, Cheng-Hsun
Tang, Ren-Bin
Schwarz, Tino F.
Esposito, Susanna
Frenette, Louise
Giaquinto, Carlo
McNeil, Shelly
Rheault, Paul
Durando, Paolo
Horn, Michael
Klar, Maximilian
Poncelet, Sylviane
De Simoni, Stephanie
Friel, Damien
De Muynck, Benoit
Suryakiran, Pemmaraju V.
Hezareh, Marjan
Descamps, Dominique
Thomas, Florence
Struyf, Frank
JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (04): : 525 - 536
[36] Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial
Lehtinen, Matti
Eriksson, Tiina
Apter, Dan
Hokkanen, Mari
Natunen, Kari
Paavonen, Jorma
Pukkala, Eero
Angelo, Maria-Genalin
Zima, Julia
David, Marie-Pierre
Datta, Sanjoy
Bi, Dan
Struyf, Frank
Dubin, Gary
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (12) : 3177 - 3185
[37] Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2-and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial
Leung, Ting Fan
Liu, Anthony Pak-Yin
Lim, Fong Seng
Thollot, Franck
Oh, Helen May Lin
Lee, Bee Wah
Rombo, Lars
Tan, Ngiap Chuan
Rouzier, Roman
Friel, Damien
De Muynck, Benoit
De Simoni, Stephanie
Suryakiran, Pemmaraju
Hezareh, Marjan
Folschweiller, Nicolas
Thomas, Florence
Struyf, Frank
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (07) : 1689 - 1702
[38] Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
Romanowski, B.
de Borba, P. Colares
Naud, P. S.
Roteli-Martins, C. M.
De Carvalho, N. S.
Teixeira, J. C.
Aoki, F.
Ramjattan, B.
Shier, R. M.
Somani, R.
Barbier, S.
Blatter, M. M.
Chambers, C.
Ferris, D.
Gall, S. A.
Guerra, F. A.
Harper, D. M.
Hedrick, J. A.
Henry, D. C.
Korn, A. P.
Kroll, R.
Moscicki, A-B
Rosenfeld, W. D.
Sullivan, B. J.
Thoming, C. S.
Tyring, S. K.
Wheeler, C. M.
Dubin, G.
Schuind, A.
Zahaf, T.
LANCET, 2009, 374 (9706): : 1975 - 1985
[39] Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial
Zhu, Feng-cai
Chen, Wen
Hu, Yue-Mei
Hong, Ying
Li, Juan
Zhang, Xun
Zhang, Yi-Ju
Pan, Qin-Jing
Zhao, Fang-Hui
Yu, Jia-Xi
Zhang, Yan-Shu
Yang, Xiaoping
Zhang, Cheng-Fu
Tang, Haiwen
Zhang, Helen
Lebacq, Marie
David, Marie-Pierre
Datta, Sanjoy K.
Struyf, Frank
Bi, Dan
Descamps, Dominique
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (11) : 2612 - 2622
[40] Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10-25-Year-Old HIV-Seronegative African Girls and Young Women
Sow, Papa Salif
Watson-Jones, Deborah
Kiviat, Nancy
Changalucha, John
Mbaye, Khardiata Diallo
Brown, Joelle
Bousso, Kouro
Kavishe, Bazil
Andreasen, Aura
Toure, Macoumba
Kapiga, Saidi
Mayaud, Philippe
Hayes, Richard
Lebacq, Marie
Herazeh, Marjan
Thomas, Florence
Descamps, Dominique
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (11): : 1753 - 1763

← 1 2 3 4 5 →